Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Metastasis regulation by PPARD expression in cancer cells
Xiangsheng Zuo, Weiguo Xu, Min Xu, Rui Tian, Micheline J. Moussalli, Fei Mao, Xiaofeng Zheng, Jing Wang, Jeffrey S. Morris, Mihai Gagea, Cathy Eng, Scott Kopetz, Dipen M. Maru, Asif Rashid, Russell Broaddus, Daoyan Wei, Mien-Chie Hung, Anil K. Sood, Imad Shureiqi
Xiangsheng Zuo, Weiguo Xu, Min Xu, Rui Tian, Micheline J. Moussalli, Fei Mao, Xiaofeng Zheng, Jing Wang, Jeffrey S. Morris, Mihai Gagea, Cathy Eng, Scott Kopetz, Dipen M. Maru, Asif Rashid, Russell Broaddus, Daoyan Wei, Mien-Chie Hung, Anil K. Sood, Imad Shureiqi
View: Text | PDF
Research Article Oncology

Metastasis regulation by PPARD expression in cancer cells

  • Text
  • PDF
Abstract

Peroxisome proliferator–activated receptor–δ (PPARD) is upregulated in many major human cancers, but the role that its expression in cancer cells has in metastasis remains poorly understood. Here, we show that specific PPARD downregulation or genetic deletion of PPARD in cancer cells significantly repressed metastasis in various cancer models in vivo. Mechanistically, PPARD promoted angiogenesis via interleukin 8 in vivo and in vitro. Analysis of transcriptome profiling of HCT116 colon cancer cells with or without genetic deletion of PPARD and gene expression patterns in The Cancer Genome Atlas colorectal adenocarcinoma database identified novel pro-metastatic genes (GJA1, VIM, SPARC, STC1, SNCG) as PPARD targets. PPARD expression in cancer cells drastically affected epithelial-mesenchymal transition, migration, and invasion, further underscoring its necessity for metastasis. Clinically, high PPARD expression in various major human cancers (e.g., colorectal, lung, breast) was associated with significantly reduced metastasis-free survival. Our results demonstrate that PPARD, a druggable protein, is an important molecular target in metastatic cancer.

Authors

Xiangsheng Zuo, Weiguo Xu, Min Xu, Rui Tian, Micheline J. Moussalli, Fei Mao, Xiaofeng Zheng, Jing Wang, Jeffrey S. Morris, Mihai Gagea, Cathy Eng, Scott Kopetz, Dipen M. Maru, Asif Rashid, Russell Broaddus, Daoyan Wei, Mien-Chie Hung, Anil K. Sood, Imad Shureiqi

×

Figure 4

Effects of PPARD on the metastasis of Panc-02 and 4T1 cells in mouse orthotopic models.

Options: View larger image (or click on image) Download as PowerPoint
Effects of PPARD on the metastasis of Panc-02 and 4T1 cells in mouse ort...
(A–D) WT Panc-02 cells or Panc-02 cells stably transfected with PPARD-shRNA-A (PPARD-shRNA-A-clone1 or -clone2) or control-shRNA plasmid were injected into the pancreases of syngeneic C57BL/6 mice, and liver metastasis formation was evaluated 4 weeks later (n = 7–10 per group). (A and B) Representative photographs of freshly isolated pancreatic tumors (A) and livers (B). Arrows indicate liver metastases. (C) Pancreatic primary tumor weight per mouse for each group. (D) Numbers of liver metastases per mouse for each group. (E–H) WT 4T1 cells or 4T1 cells stably transduced with PPARD-shRNA-C or -D or control-shRNA lentivirus were injected into the mammary fat pads of syngeneic BALB/c mice (n = 6 per group), and primary mammary tumors were removed when reaching a predetermined size of 10 mm at the greatest diameter. Lung metastasis formation was evaluated 2 weeks later via lung CT and lung surface tumor count. (E) Mammary primary tumor weight per mouse for each group. (F) Numbers of lung metastases per mouse for each group. (G) Representative photographs of formalin-fixed primary mammary tumors. (H) Representative CT images of lungs (upper panel) and Davidson’s solution–fixed lungs (lower panel). Arrows indicate lung metastases. All scale bars: 1 cm. Values in C–F are mean ± SEM. **P < 0.001, ***P < 0.0001 (2-way ANOVA for C and E and 2-sided Poisson for D and F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts